NL-OMON44574招募中4 期
Therapeutic drug monitoring in tocilizumab-treated rheumatoid arthritis patients: Pilot study of a double-blind randomised controlled trial - TDM tocilizumab
Amsterdam Rheumatology and immunology Center | Reade0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •RA according to the ACR 1987 or 2010 criteria;
- •Current use of tocilizumab iv, with a consistent interval of 4 weeks for at least 24 weeks.
排除标准
- •Scheduled surgery in the next 20 weeks or other preplanned reasons for treatment discontinuation.
研究者
相似试验
尚未招募
4 期
Determination of tocilizumab trough levels during dose tapering in patients with rheumatoid arthritis (OPTIRA study)Rheumatoid arthritisNL-OMON53280Franciscus Gasthuis & Vlietland46
已完成
不适用
The effect of monitoring of tobramycin levels in blood in patients with cystic fibrosis.Cystic fibrosisNL-OMON20263AMC35
招募中
2 期
Evaluation of the Effects of Tocilizumab Administration in Hospitalized COVID-19 PatientsIRCT20151227025726N29Iran University of Medical Sciences50
已完成
不适用
Clinical trial of efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHDThe patients with systemic sclerosis or sclerodermatous chronic GVHD.JPRN-UMIN000020389Kanazawa University Hospital, Department of dermatology5
招募中
不适用
Therapeutic Drug Monitoring in tuberculosis patients. Setup and optimisation of therapeutic drug monitoring at the Research Center BorstelA15.9Respiratory tuberculosis unspecified, confirmed bacteriologically and histologicallyDRKS00009869Medizinische Klinik des Foschungszentrums Borstel20